Subunit Vaccines

Vaccines Development and Manufacturing

Recombinant protein vaccines represent a critical class of vaccines designed to elicit a targeted immune response. They also offer improved safety profiles compared with other vaccine platforms. These protein-based vaccines require complex manufacturing processes that demand expertise, precision, and compliance with stringent regulatory standards.

Our CDMO excels in providing advanced manufacturing services for protein vaccine antigens. We offer comprehensive support at every stage of the product lifecycle, from early-stage development to full-scale commercial production. Mabion have extensive experience in upstream and downstream processing, stringent process validation, and seamless logistics management. This expertise enables us to deliver high-quality recombinant antigens for a broad range of subunit vaccine applications. Our services are tailored to ensure that your product consistently meets regulatory requirements while maintaining efficacy, safety, and stability.

Our expert team recognizes that each vaccine, regardless of type, presents unique challenges and requires a customized manufacturing approach. We leverage our extensive knowledge and state-of-the-art technology to optimize every step of the production process. This approach enables us to achieve exceptional results in terms of both timelines and product yield. We offer contract manufacturing of antigens for vaccines such as:

• Influenza vaccine
• COVID-19 vaccine
• Hepatitis B vaccine
• HPV vaccine
• RSV vaccine
• Shingles vaccine
• Chickenpox vaccine
• Monkeypox vaccine
• Rotavirus vaccine
• Malaria vaccine
• Cholera vaccine
• Dengue vaccine
• Ebola vaccine
• Haemophilus influenzae type B vaccine

We are also open to co-development of vaccines for less common infectious diseases and the development of orphan innovative biologics.

Mabion has extensive experience in vaccine manufacturing. Discover more about our expertise in our case study highlighting our collaboration with Novavax on the COVID-19 vaccine.